Derksen Rh
Impact in
- Rheumatology top 1%
- Systemic Lupus Erythematosus Research
- Hematology top 5%
- Platelet Disorders and Treatments
- Blood Coagulation and Thrombosis Mechanisms
Papers in
- Rheumatology 11
- Systemic Lupus Erythematosus Research 11
-
- Platelet Disorders and Treatments 5
- Blood Coagulation and Thrombosis Mechanisms 2
- Co-authors
- Tilman M. Hackeng (2 shared papers)PG de Groot (1 shared paper)L Kater (7 shared papers)A Struyvenberg (2 shared papers)Marja van Vliet (2 shared papers)H K Nieuwenhuis (2 shared papers)L. Kater (1 shared paper)Asherson Ra (1 shared paper)
- Journals
- Blood (4 papers)PubMed (10 papers)
- Partner nations
- Netherlands
In The Last Decade
Derksen Rh
14 papers receiving 625 citations
Peers
Comparison fields: 5 of 49
- Rheumatology 530
- Hematology 301
- Nephrology 84
- Internal Medicine 23
- Immunology and Allergy 40
Countries citing papers authored by Derksen Rh
This map shows the geographic impact of Derksen Rh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derksen Rh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derksen Rh more than expected).
Fields of papers citing papers by Derksen Rh
This network shows the impact of papers produced by Derksen Rh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derksen Rh. The network helps show where Derksen Rh may publish in the future.
Co-authors
The 15 scholars most cited alongside Derksen Rh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 393 | |
| 2 | Lupus anticoagulant: revival of an old phenomenon. | 1986 | 64 |
| 3 | Large vessel occlusion and gangrene in systemic lupus erythematosus and "lupus-like" disease. A report of six cases. | 1986 | 51 |
| 4 | 1991 | 46 | |
| 5 | The efficacy of plasma exchange in the removal of plasma components. | 1984 | 37 |
| 6 | Prospective multicentre trial on the short-term effects of plasma exchange versus cytotoxic drugs in steroid-resistant lupus nephritis. | 1988 | 28 |
| 7 | Effect of plasmapheresis in active systemic lupus erythematosus. | 1981 | 14 |
| 8 | 1993 | 10 | |
| 9 | Therapy of proliferative lupus glomerulonephritis: a prospective trial in The Netherlands. | 1994 | 8 |
| 10 | [Immunology in medical practice. II. Antiphospholipid antibodies in pregnancy]. | 1997 | 4 |
| 11 | Antiphospholipid antibodies: risk factors or only markers for thrombosis, fetal loss and thrombocytopenia? | 1990 | 3 |
| 12 | 1991 | 2 | |
| 13 | Plasma exchange in the treatment of cryoglobulinaemia. | 1983 | 1 |
| 14 | Wegener's granulomatosis and cyclosporine. | 1988 | 1 |
About Derksen Rh
Derksen Rh is a scholar working on Rheumatology, Hematology, Genetics, Nephrology and Pulmonary and Respiratory Medicine, having authored 14 papers that have together received 662 indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (11 papers), Platelet Disorders and Treatments (5 papers), Blood disorders and treatments (4 papers), Renal Diseases and Glomerulopathies (2 papers), Blood Coagulation and Thrombosis Mechanisms (2 papers), Pregnancy and Medication Impact (2 papers), Blood properties and coagulation (1 paper) and Liver Diseases and Immunity (1 paper). The work is most often cited by research in Rheumatology (530 citations), Hematology (301 citations), Nephrology (84 citations), Internal Medicine (23 citations) and Immunology and Allergy (40 citations). Derksen Rh has collaborated with scholars based in Netherlands. Frequent co-authors include Tilman M. Hackeng, PG de Groot, L Kater, A Struyvenberg, Marja van Vliet, H K Nieuwenhuis, L. Kater, Asherson Ra, Gharavi Ae and Harris En. Their work appears in journals such as Blood and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.